Hop til indhold
Dansk Forskningscenter for Lungekræft

Dansk Forskningscenter for Lungekræft

  • Vores rolle
  • Målgruppe
  • Projekter
    • Projektgrupper og protokoller
    • CP1 – Lungreach
    • CP2 – Early detection
    • CP3 – Improves imaging
    • CP4 – NEBULA
    • CP5 – SUPE-R
    • CP6 – Improves Radiotherapy
    • CP7 – Functional capaticy
    • CP8 – ProWide
    • CP9 – Smoking-cessation
    • CP10 – Epidemiologi and mortality
    • AP1 – Artificial intelligence
    • AP2 – Socially vulnerable patients
    • AP3 – Dynamic measurement of treatment response in advanced non-small cell lung cancer
    • AP4 Onkologidata i Dansk Lunge Cancer Register
    • AP5 – Effect of singing training
    • Venous thromboembolism
  • Bestyrelse
  • Ansøgning
  • Publikationer
  • Kontakt
  • DanskDansk
    • EnglishEnglish

Publikationer

  1. Skougaard K, Østrup O et.al: Surveillance with PET/CT and Liquid Biopsies of Stage I-III Lung Cancer Patients After Completion ofDefinitive Therapy: A Randomized Controlles Trial (SUPER) Clinical Lung Cancer, 2020-0301 Volume 21, Issue 2: e61-e64.
  2. Frank M, Bødtger U et. al: Re-biopsy after first line treatment in advances NSCLC can reveal changes in PD-L1 expression Lung Cancer, Volume 149: 23-32.
  3. L. Winther, Kr. Larsen, WE. Langer, M. Quist: THE 6-MINUTE WALK TEST AS A PRE-TREATMENT PREDICTOR FOR ADVERSE EVENTS IN PATIENTS WITH LUNG CANCER: A FEASIBILITY STUDY
  4. Malene Støchkel Frank, Uffe Bodtger, Julie Gehl and Lise Barlebo Ahlborn: Actionable Molecular Alterations are Revealed in Majority of Advanced NOn-Small Cell Lunge Cancer Patients by Genomic Tumor Profiling at Progression after First Line Treatment